Onconetix, Inc. — Director's Dealing 2024

Nov 1, 2024

SEC Form 3/A — Form 3/A

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2024-09-24

Reporting Person: Altos Venture AG (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Make-whole right (right to acquire)	$	2025-06-23	Common Stock ()		Direct

Footnotes

F1: Pursuant to a Subscription Agreement with the Issuer dated December 15, 2023, the Reporting Person purchased Units of Common Stock and warrants (immediately exercised) on September 24, 2024. Under a make-whole provision in the Subscription Agreement, the Issuer agreed to adjust the price for the Units by issuing additional shares of Common Stock to the Reporting Person on June 23, 2025 in the event that the Issuer VWAP during the period from September 25, 2024 through June 21, 2025 is less than $10.00. "Issuer VWAP" for this purpose means the average of the daily volume-weighted average prices of the Common Stock on Nasdaq for completed trading days, as reported on Bloomberg or, if not reported thereby, any other authoritative source.